2022 Q3 Form 10-Q Financial Statement

#000185173422000443 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $6.427M $7.397M $8.074M
YoY Change 23.15% 36.15% 85.14%
Cost Of Revenue $3.671M $4.558M $4.434M
YoY Change 58.92% 63.14% 128.2%
Gross Profit $2.756M $2.839M $3.640M
YoY Change -5.26% 7.58% 50.54%
Gross Profit Margin 42.88% 38.38% 45.08%
Selling, General & Admin $2.701M $2.657M $3.262M
YoY Change 6.93% -5.34% 23.65%
% of Gross Profit 98.0% 93.59% 89.62%
Research & Development $9.000K $744.0K $11.00K
YoY Change 80.0% 22.22%
% of Gross Profit 0.33% 26.21% 0.3%
Depreciation & Amortization $55.00K $122.0K $67.00K
YoY Change 3.77% 134.62% 34.0%
% of Gross Profit 2.0% 4.3% 1.84%
Operating Expenses $6.381M $7.959M $7.707M
YoY Change 31.81% 42.1% 191.16%
Operating Profit $46.00K -$562.0K $400.0K
YoY Change -87.83% 234.52% -274.67%
Interest Expense $7.000K $91.00K $1.000K
YoY Change 250.0% 2933.33% -100.0%
% of Operating Profit 15.22% 0.25%
Other Income/Expense, Net $240.0K -$74.00K $339.0K
YoY Change -91.21% -100.37% 6680.0%
Pretax Income $286.0K -$636.0K $706.0K
YoY Change -90.79% -103.22% -103.51%
Income Tax $45.00K
% Of Pretax Income 15.73%
Net Earnings $241.0K -$636.0K $700.0K
YoY Change -92.24% -103.22% -103.48%
Net Earnings / Revenue 3.75% -8.6% 8.67%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 217.7M 212.1M 211.0M
Diluted Shares Outstanding 244.1M 212.1M 242.9M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $466.0K $488.0K $409.0K
YoY Change -63.31% -75.11% -88.16%
Cash & Equivalents $466.0K $488.0K $409.0K
Short-Term Investments
Other Short-Term Assets $950.0K $896.0K $1.226M
YoY Change -18.17% 11.44% 246.33%
Inventory $5.129M $5.634M $4.696M
Prepaid Expenses
Receivables $1.600M $1.768M $1.717M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.100M $8.800M $8.000M
YoY Change 42.93% 44.33% 23.44%
LONG-TERM ASSETS
Property, Plant & Equipment $352.0K $331.0K $449.0K
YoY Change -21.6% -29.42% -71.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.00K $82.00K $70.00K
YoY Change 31.34% 22.39% -1.41%
Total Long-Term Assets $1.326M $953.0K $1.157M
YoY Change -4.26% -37.1% -30.22%
TOTAL ASSETS
Total Short-Term Assets $8.100M $8.800M $8.000M
Total Long-Term Assets $1.326M $953.0K $1.157M
Total Assets $9.471M $9.739M $9.205M
YoY Change 34.3% 27.94% 13.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.506M $2.439M $1.806M
YoY Change 120.5% 153.8% 407.3%
Accrued Expenses $1.636M $1.589M $1.801M
YoY Change -4.61% -20.19% -21.46%
Deferred Revenue $245.0K $203.0K $316.0K
YoY Change 10.86%
Short-Term Debt $298.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $1.000M $1.000M
YoY Change
Total Short-Term Liabilities $5.300M $6.000M $4.800M
YoY Change 2.67% -31.91% -83.56%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $150.0K $150.0K
YoY Change -55.09% -55.09% -84.77%
Other Long-Term Liabilities $526.0K $318.0K $376.0K
YoY Change 7.79% -41.22% -41.34%
Total Long-Term Liabilities $676.0K $468.0K $526.0K
YoY Change -17.76% -46.51% -67.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.300M $6.000M $4.800M
Total Long-Term Liabilities $676.0K $468.0K $526.0K
Total Liabilities $5.942M $6.482M $5.350M
YoY Change -0.7% -33.09% -82.64%
SHAREHOLDERS EQUITY
Retained Earnings -$4.544M -$4.785M -$4.149M
YoY Change -34.42% -52.32%
Common Stock $218.0K $218.0K $217.0K
YoY Change 3.81% 7.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.529M $3.300M $3.855M
YoY Change
Total Liabilities & Shareholders Equity $9.471M $9.739M $9.205M
YoY Change 34.3% 27.94% 13.1%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $241.0K -$636.0K $700.0K
YoY Change -92.24% -103.22% -103.48%
Depreciation, Depletion And Amortization $55.00K $122.0K $67.00K
YoY Change 3.77% 134.62% 34.0%
Cash From Operating Activities -$246.0K -$904.0K -$400.0K
YoY Change -62.44% 52.45% -249.25%
INVESTING ACTIVITIES
Capital Expenditures -$76.00K -$17.00K $85.00K
YoY Change 130.3% -19.05% 347.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$76.00K -$17.00K -$85.00K
YoY Change 130.3% -19.05% 347.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 1.000M $0.00
YoY Change -10100.0% -213.64% -100.0%
NET CHANGE
Cash From Operating Activities -246.0K -904.0K -$400.0K
Cash From Investing Activities -76.00K -17.00K -$85.00K
Cash From Financing Activities 300.0K 1.000M $0.00
Net Change In Cash -22.00K 79.00K -$457.0K
YoY Change -96.82% -105.29% -122.48%
FREE CASH FLOW
Cash From Operating Activities -$246.0K -$904.0K -$400.0K
Capital Expenditures -$76.00K -$17.00K $85.00K
Free Cash Flow -$170.0K -$887.0K -$485.0K
YoY Change -72.67% 55.07% -294.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4042000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217726053
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217726053
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
210890930
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
210890930
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32420
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1575085
dei Entity Address Address Line1
EntityAddressAddressLine1
1007 Brioso Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Costa Mesa
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92627
dei City Area Code
CityAreaCode
949)
dei Local Phone Number
LocalPhoneNumber
531-6855
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
217726053
CY2022Q2 us-gaap Cash
Cash
488000 usd
CY2021Q4 us-gaap Cash
Cash
866000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1768000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1368000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
5634000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
5005000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
896000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
755000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
8786000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
7994000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
331000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
540000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
755000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
953000 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1254000 usd
CY2022Q2 us-gaap Assets
Assets
9739000 usd
CY2021Q4 us-gaap Assets
Assets
9248000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4068000 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1000000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
547000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
899000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
222000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
329000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
203000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
238000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6014000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5534000 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
150000 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
150000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
318000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
433000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
468000 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
583000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
6482000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
6117000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
218000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
211000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7824000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7775000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4785000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4855000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3257000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3131000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9739000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9248000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7397000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5433000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15471000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9794000 usd
CY2022Q2 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
4558000 usd
CY2021Q2 chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
2794000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
8992000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
4737000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1870000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2457000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4429000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4675000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
787000 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
350000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1490000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
770000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
744000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
755000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7959000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5601000 usd
us-gaap Operating Expenses
OperatingExpenses
15666000 usd
us-gaap Operating Expenses
OperatingExpenses
10191000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-562000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-168000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-195000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-397000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
91000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
3000 usd
us-gaap Interest Expense
InterestExpense
92000 usd
us-gaap Interest Expense
InterestExpense
31000 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
12000 usd
CY2021Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
19274000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
352000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-828000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
658000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
875000 usd
CY2022Q2 us-gaap Other Income
OtherIncome
5000 usd
CY2021Q2 us-gaap Other Income
OtherIncome
3000 usd
us-gaap Other Income
OtherIncome
5000 usd
us-gaap Other Income
OtherIncome
8000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-74000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19932000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-636000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
19764000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
us-gaap Net Income Loss
NetIncomeLoss
-373000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212051322
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202033912
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211532305
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198606970
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212051322
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278405524
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
242800475
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198606970
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3855000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-636000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3257000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-22684000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
680000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
165000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
19764000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2075000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3131000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3257000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5996000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000000 usd
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
770000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
524000 usd
us-gaap Net Income Loss
NetIncomeLoss
-373000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2075000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
us-gaap Net Income Loss
NetIncomeLoss
-373000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
187000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
189000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
102000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-13000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
352000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-828000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
215000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
221000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
56000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
524000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
875000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
308000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
821000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
587000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
107000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
629000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
395000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
141000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
354000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-17000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-35000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
320000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-222000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-224000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1276000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-325000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
184000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1400000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
usd
us-gaap Payments Of Dividends
PaymentsOfDividends
880000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-378000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
539000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
866000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-195000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
904000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1422000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
488000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1961000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
150000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
770000 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1300000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3300000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
8800000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
8000000.0 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6000000.0 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4800000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/>
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
899000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
352000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
547000 usd
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 usd
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
949000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1104000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
618000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
673000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
331000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
431000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
122000 usd
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
189000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
102000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2439000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2476000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
911000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
902000 usd
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
236000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
342000.00 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
456000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
348000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4042000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4068000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1000000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2022Q2 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
150000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1150000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-636000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19764000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
70000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-373000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
19274000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
352000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-636000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
490000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-282000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-373000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212051322
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202033912
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211532305
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
198606970
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5437099
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
31442211
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2021Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
39492302
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
31268169
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212051322
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
278405524
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
242800475
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
198606970
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
619000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46548000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87333000
CY2020Q2 chuc Share Exchange Value Per Share
ShareExchangeValuePerShare
0.44313
CY2021Q2 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
1736501
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.44313
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.853
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
3000000.0 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7123000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.54
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
913000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.44
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6210000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
6353000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
116000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
139000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
255000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
149000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
116000 usd
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
139000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
255000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
149000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
119000 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
139000 usd
us-gaap Lease Cost
LeaseCost
258000 usd
us-gaap Lease Cost
LeaseCost
149000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
261000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
221000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
138000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
275000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
206000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
79000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
540000 usd

Files In Submission

Name View Source Status
0001851734-22-000443-index-headers.html Edgar Link pending
0001851734-22-000443-index.html Edgar Link pending
0001851734-22-000443.txt Edgar Link pending
0001851734-22-000443-xbrl.zip Edgar Link pending
chuc-20220630.xsd Edgar Link pending
chuc-20220630_cal.xml Edgar Link unprocessable
chuc-20220630_def.xml Edgar Link unprocessable
chuc-20220630_lab.xml Edgar Link unprocessable
chuc-20220630_pre.xml Edgar Link unprocessable
chuc20220630_10q.htm Edgar Link pending
ex_409260.htm Edgar Link pending
ex_409261.htm Edgar Link pending
ex_409262.htm Edgar Link pending
ex_409263.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
chuc20220630_10q_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable